The Centre has said the requirement for cold storage may change with the arrival of other COVID-19 vaccines in the future and it is fully prepared to take appropriate steps as and when such vaccines are available.
Russia has reported 125,853 deaths from COVID-19 since the pandemic started, but statistics showing excess mortality over the past year suggest the real number is far higher.
DRL said the pilot launch would help test cold storage and other logistical arrangements before the vaccine's commercial launch.
According to a release by Rockwell, the vaccine freezer plays a very critical role in the safety of vaccines and its potency as Russias Sputnik V vaccine, made available in India through Dr Reddy's, requires a temperature range of minus -18 degrees celsius, to keep the vaccine stable and potent.
A bench of Justices Manmohan and Najmi Waziri also termed as disturbing the Centre's reply, filed in the matter, saying the authorities were virtually saying they are not aware of what the firm has been doing and its relation with Sputnik.
The vaccine has a proven efficacy rate of 91.5 percent, which is the highest after the candidates of Moderna Inc and Pfizer-BioNTech.
It is a two-dose vaccine. You take the first dose on day zero and the second one on day 21. The peak immunity develops somewhere between day 28 to day 42. So, it is a two-dose vaccine and we expect it to be available in the next few weeks,” Deepak Sapra, the company's CEO, APIs and Services, said.
The results, collated by the Gamaleya Institute in Moscow that developed and tested the Sputnik V COVID-19 vaccine, were in line with efficacy data reported at earlier stages of the trial, which has been running in Moscow since September.
Iran's Supreme Leader Ayatollah Ali Khamenei this month banned the use of vaccines made by the United States and Britain, calling the jabs "completely untrustworthy".
The Sputnik V vaccine, which Russia already started supplying to other countries, is administered in two doses, which use different components, 21 days apart.
Russia launched a voluntary vaccination programme with the Russia-made Sputnik V vaccine earlier in December, starting with the most vulnerable groups in Moscow.
More than 100,000 people have already been vaccinated against the disease as part of Russia's mass inoculation programme, which began in September alongside a Moscow-based human trial of the shot.
Certain questions need to be accorded top priority while planning the way in the Indian COVID-19 immunisation programme, which must be accentuated with novel steps and innovations at the grass-roots level catering to all
The decision to conduct the human clinical trials of the vaccine was taken after Dr Reddy''s Laboratories got approval from the Drugs Controller General of India (DCGI) in this regard, an official said.
Russian President Vladimir Putin has offered to provide staff of United Nations with the Sputnik V vaccine in a speech to this year's General Assembly marking the body's 75th birthday.